First Time Loading...

C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 6.74 USD 4.82% Market Closed
Updated: May 5, 2024

C4 Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

C4 Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
C4 Therapeutics Inc
NASDAQ:CCCC
EPS (Diluted)
-$2
CAGR 3-Years
-20%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
18%
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$12
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$13
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$34
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
23%

See Also

What is C4 Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-2.7 USD

Based on the financial report for Dec 31, 2023, C4 Therapeutics Inc's EPS (Diluted) amounts to -2.7 USD.

What is C4 Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-36%

Over the last year, the EPS (Diluted) growth was -2%. The average annual EPS (Diluted) growth rates for C4 Therapeutics Inc have been -20% over the past three years , -36% over the past five years .